S.954 - Affordable Insulin Now Act of 2023

The Affordable Insulin Now Act of 2023 aims to cap the monthly cost of insulin at $35 for both insured and uninsured patients. It mandates that private insurance plans cover at least one insulin type per form (vial, pen) and establishes a program to reimburse healthcare providers for providing low-cost insulin to uninsured patients. The goal is to reduce long-term healthcare costs and prevent diabetes-related complications.​ Learn more…